[Congressional Record Volume 162, Number 32 (Monday, February 29, 2016)]
[Senate]
[Page S1093]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3333. Mr. BLUMENTHAL submitted an amendment intended to be 
proposed by him to the bill S. 524, to authorize the Attorney General 
to award grants to address the national epidemics of prescription 
opioid abuse and heroin use; which was ordered to lie on the table; as 
follows:
       At the end, add the following:

     SEC. 705. REMS FOR IMMEDIATE RELEASE OPIOID ANALGESICS.

       Not later than 120 days after the date of enactment of this 
     Act, the Secretary of Health and Human Services shall require 
     a risk evaluation and mitigation strategy under section 505-1 
     of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1) 
     to be submitted for drugs that are immediate release opioid 
     analgesics, including for such drugs for which there is an 
     approved covered application (as defined in such section) and 
     for such drugs for which a covered application has been 
     submitted but not yet approved.
                                 ______